• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

止血异常与肝脏疾病。

Hemostatic abnormalities and liver diseases.

作者信息

Wada Hideo, Usui Masanobu, Sakuragawa Nobuo

机构信息

Departments of Molecular and Laboratory Medicine, Mie University Graduate School of Medicine, Tsu-city, Japan.

出版信息

Semin Thromb Hemost. 2008 Nov;34(8):772-8. doi: 10.1055/s-0029-1145259. Epub 2009 Feb 12.

DOI:10.1055/s-0029-1145259
PMID:19214915
Abstract

Professor Eberhard F. Mammen greatly contributed to the understanding of the relationship between hemostatic abnormalities and liver diseases. The physiology of the hemostatic system is closely linked to liver function because the liver parenchymal cells produce most of the factors of the clotting and fibrinolytic systems. Acute or chronic hepatocellular diseases and hepatic failure including liver cirrhosis, vitamin K deficiency, liver surgery including liver transplantation, and sclerotherapy of bleeding esophageal varices, which were classified by Prof. Mammen, show various hemostatic abnormalities in the coagulation system, fibrinolytic system, platelets, and the reticuloendothelial system. Hemostatic abnormalities in patients with hepatic failure or in those that have undergone liver surgery are similar to those in disseminated intravascular coagulation. Prof. Mammen also contributed to the study of vitamin K-dependent clotting factors, antithrombin, and hemostatic molecular markers. Partly based on this work, the prothrombin time-international normalized ratio, several hemostatic molecular markers, and antithrombin therapy have been recently developed for the diagnosis and treatment of thrombosis.

摘要

埃伯哈德·F·马门教授为人们理解止血异常与肝脏疾病之间的关系做出了巨大贡献。止血系统的生理学与肝功能密切相关,因为肝实质细胞产生凝血和纤溶系统的大部分因子。马门教授所分类的急性或慢性肝细胞疾病及肝衰竭(包括肝硬化)、维生素K缺乏、肝脏手术(包括肝移植)以及出血性食管静脉曲张硬化疗法,在凝血系统、纤溶系统、血小板和网状内皮系统中呈现出各种止血异常。肝衰竭患者或接受肝脏手术患者的止血异常与弥散性血管内凝血患者的相似。马门教授还对维生素K依赖凝血因子、抗凝血酶及止血分子标志物的研究做出了贡献。部分基于这项工作,最近已开发出凝血酶原时间-国际标准化比值、多种止血分子标志物及抗凝血酶疗法用于血栓形成的诊断和治疗。

相似文献

1
Hemostatic abnormalities and liver diseases.止血异常与肝脏疾病。
Semin Thromb Hemost. 2008 Nov;34(8):772-8. doi: 10.1055/s-0029-1145259. Epub 2009 Feb 12.
2
Coagulation abnormalities in liver disease.肝病中的凝血异常。
Hematol Oncol Clin North Am. 1992 Dec;6(6):1247-57.
3
Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment.肝病中的止血改变:病理生理学、临床后果及治疗综述
Dig Surg. 2007;24(4):250-8. doi: 10.1159/000103655. Epub 2007 Jul 27.
4
Acquired coagulation disorders.获得性凝血障碍
Clin Haematol. 1985 Jun;14(2):413-42.
5
Coagulation abnormalities in patients who have liver disease.患有肝脏疾病患者的凝血异常。
Clin Liver Dis. 2006 Aug;10(3):665-78, x-xi. doi: 10.1016/j.cld.2006.08.006.
6
Hemostatic defects in end stage liver disease.终末期肝病的止血缺陷
Crit Care Clin. 2005 Jul;21(3):563-87. doi: 10.1016/j.ccc.2005.03.002.
7
[The mechanisms of disorders in the hemostatic system of patients with chronic diffuse liver diseases].[慢性弥漫性肝病患者止血系统紊乱的机制]
Ter Arkh. 1990;62(2):72-6.
8
Review article: coagulation disorders in chronic liver disease.综述文章:慢性肝病中的凝血障碍
Aliment Pharmacol Ther. 2007 Nov;26 Suppl 1:21-8. doi: 10.1111/j.1365-2036.2007.03509.x.
9
Blood clotting abnormalities in liver disease.肝病中的凝血异常。
Prog Liver Dis. 1976;5:350-62.
10
[Liver diseases and hemostasis].[肝脏疾病与止血]
Pathol Biol (Paris). 1999 Nov;47(9):1006-15.

引用本文的文献

1
Prevalence of chronic venous insufficiency and deep vein thrombosis in cirrhotic patients.肝硬化患者慢性静脉功能不全和深静脉血栓形成的患病率。
Front Med (Lausanne). 2023 Sep 27;10:1214517. doi: 10.3389/fmed.2023.1214517. eCollection 2023.
2
Spontaneous Rupture of the Internal Thoracic Artery Causing a Mediastinal Hematoma in a Patient with Alcoholic Liver Cirrhosis: A Case Report.酒精性肝硬化患者胸内动脉自发性破裂致纵隔血肿:一例报告
J Korean Soc Radiol. 2023 May;84(3):750-756. doi: 10.3348/jksr.2022.0105. Epub 2023 Apr 13.
3
Autoimmune Diseases Affecting Hemostasis: A Narrative Review.
自身免疫性疾病对止血的影响:一篇叙述性综述。
Int J Mol Sci. 2022 Nov 25;23(23):14715. doi: 10.3390/ijms232314715.
4
Is the platelet function test effective in predicting blood loss in patients undergoing hepatic resection?血小板功能测试对预测肝切除患者的失血量有效吗?
Ann Surg Treat Res. 2022 Oct;103(4):227-234. doi: 10.4174/astr.2022.103.4.227. Epub 2022 Oct 7.
5
Multi-center validation of machine learning model for preoperative prediction of postoperative mortality.用于术后死亡率术前预测的机器学习模型的多中心验证
NPJ Digit Med. 2022 Jul 12;5(1):91. doi: 10.1038/s41746-022-00625-6.
6
Prognostic value of albumin-related ratios in HBV-associated decompensated cirrhosis.白蛋白相关比值对乙型肝炎相关性失代偿性肝硬化的预后价值。
J Clin Lab Anal. 2022 Apr;36(4):e24338. doi: 10.1002/jcla.24338. Epub 2022 Mar 17.
7
Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study.维生素 K 在纠正因肝脏疾病导致的危重患者 INR 升高中的应用适宜性:一项观察性研究。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211050923. doi: 10.1177/10760296211050923.
8
Toxic Effect of Aflatoxins in Dogs Fed Contaminated Commercial Dry Feed: A Review.喂食受污染商业干饲料的犬类中黄曲霉毒素的毒性作用:综述
Toxins (Basel). 2021 Jan 15;13(1):65. doi: 10.3390/toxins13010065.
9
Pre-Liver Transplant ROTEM™ Clot Lysis Index Is Associated with 30-Day Mortality, But Is Not a Measure for Fibrinolysis.肝移植前ROTEM™凝血块溶解指数与30天死亡率相关,但并非纤维蛋白溶解的指标。
J Clin Med. 2020 Oct 14;9(10):3298. doi: 10.3390/jcm9103298.
10
Plasma D-dimer as a novel biomarker for predicting poor outcomes in HBV-related decompensated cirrhosis.血浆D-二聚体作为预测乙型肝炎病毒相关失代偿期肝硬化不良预后的新型生物标志物。
Medicine (Baltimore). 2019 Dec;98(52):e18527. doi: 10.1097/MD.0000000000018527.